Work

Supplemental Figure S2 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Depletion of NKp46+ (A), CD90+ (B), and CD8+ (C) cells.Gating strategy to identify macrophage and MDSC populations.

DOI: 10.1158/2326-6066.22538858.v1

Authors: Marina Moskalenko, Michael Pan, Yichun Fu, Ellen H. de Moll, Daigo Hashimoto, Arthur Mortha, Marylene Leboeuf, Padmini Jayaraman, Sebastian Bernardo, Andrew G. Sikora, Jedd Wolchok, Nina Bhardwaj, Miriam Merad, Yvonne Saenger

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362540319

Cites:

Cited by:

Related to: 10